Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Lefty Glycoproteins in Human Embryonic Stem Cells: Extracellular Delivery Route and Posttranslational Modification in Differentiation.

Khalkhali-Ellis Z, Galat V, Galat Y, Gilgur A, Seftor EA, Hendrix MJ.

Stem Cells Dev. 2016 Sep 19. [Epub ahead of print]

2.

Effects of a novel Nodal-targeting monoclonal antibody in melanoma.

Strizzi L, Sandomenico A, Margaryan NV, FocĂ  A, Sanguigno L, Bodenstine TM, Chandler GS, Reed DW, Gilgur A, Seftor EA, Seftor RE, Khalkhali-Ellis Z, Leonardi A, Ruvo M, Hendrix MJ.

Oncotarget. 2015 Oct 27;6(33):34071-86. doi: 10.18632/oncotarget.6049.

3.

Two Faces of Cathepsin D: Physiological Guardian Angel and Pathological Demon.

Khalkhali-Ellis Z, Hendrix MJ.

Biol Med (Aligarh). 2014 Jul;6(2). pii: 1000206.

4.

Internalization by multiple endocytic pathways and lysosomal processing impact maspin-based therapeutics.

Bodenstine TM, Seftor RE, Seftor EA, Khalkhali-Ellis Z, Samii NA, Monarrez JC, Chandler GS, Pemberton PA, Hendrix MJ.

Mol Cancer Res. 2014 Oct;12(10):1480-91. doi: 10.1158/1541-7786.MCR-14-0067. Epub 2014 Sep 25.

5.

Divergence(s) in nodal signaling between aggressive melanoma and embryonic stem cells.

Khalkhali-Ellis Z, Kirschmann DA, Seftor EA, Gilgur A, Bodenstine TM, Hinck AP, Hendrix MJ.

Int J Cancer. 2015 Mar 1;136(5):E242-51. doi: 10.1002/ijc.29198. Epub 2014 Sep 29.

6.

Cleavage of Histone 3 by Cathepsin D in the involuting mammary gland.

Khalkhali-Ellis Z, Goossens W, Margaryan NV, Hendrix MJ.

PLoS One. 2014 Jul 23;9(7):e103230. doi: 10.1371/journal.pone.0103230. eCollection 2014.

7.

Maspin: molecular mechanisms and therapeutic implications.

Bodenstine TM, Seftor RE, Khalkhali-Ellis Z, Seftor EA, Pemberton PA, Hendrix MJ.

Cancer Metastasis Rev. 2012 Dec;31(3-4):529-51. doi: 10.1007/s10555-012-9361-0. Review.

PMID:
22752408
8.

New insights into cathepsin D in mammary tissue development and remodeling.

Margaryan NV, Kirschmann DA, Lipavsky A, Bailey CM, Hendrix MJ, Khalkhali-Ellis Z.

Cancer Biol Ther. 2010 Sep 1;10(5):457-66. Epub 2010 Oct 1.

9.

Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology.

Abbott DE, Margaryan NV, Jeruss JS, Khan S, Kaklamani V, Winchester DJ, Hansen N, Rademaker A, Khalkhali-Ellis Z, Hendrix MJ.

Cancer Biol Ther. 2010 Jan;9(1):23-30. Epub 2010 Jan 15.

10.

Temporal and spatial expression patterns for the tumor suppressor Maspin and its binding partner interferon regulatory factor 6 during breast development.

Bailey CM, Margaryan NV, Abbott DE, Schutte BC, Yang B, Khalkhali-Ellis Z, Hendrix MJ.

Dev Growth Differ. 2009 Jun;51(5):473-81. doi: 10.1111/j.1440-169X.2009.01110.x.

11.

IFN-gamma regulation of vacuolar pH, cathepsin D processing and autophagy in mammary epithelial cells.

Khalkhali-Ellis Z, Abbott DE, Bailey CM, Goossens W, Margaryan NV, Gluck SL, Reuveni M, Hendrix MJ.

J Cell Biochem. 2008 Sep 1;105(1):208-18. doi: 10.1002/jcb.21814.

12.

Interferon regulatory factor 6 promotes cell cycle arrest and is regulated by the proteasome in a cell cycle-dependent manner.

Bailey CM, Abbott DE, Margaryan NV, Khalkhali-Ellis Z, Hendrix MJ.

Mol Cell Biol. 2008 Apr;28(7):2235-43. doi: 10.1128/MCB.01866-07. Epub 2008 Jan 22.

13.

Could hormones make a difference in the treatment of juvenile rheumatoid arthritis?

Khalkhali-Ellis Z, Moore TL, Hendrix MJ.

BioDrugs. 2000 Feb;13(2):77-86.

PMID:
18034514
14.

Elucidating the function of secreted maspin: inhibiting cathepsin D-mediated matrix degradation.

Khalkhali-Ellis Z, Hendrix MJ.

Cancer Res. 2007 Apr 15;67(8):3535-9. Erratum in: Cancer Res. 2007 May 15;67(10):5060.

15.

Maspin: the new frontier.

Khalkhali-Ellis Z.

Clin Cancer Res. 2006 Dec 15;12(24):7279-83. Review.

16.

Biological functions of maspin.

Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ.

J Cell Physiol. 2006 Dec;209(3):617-24. Review.

PMID:
17001697
17.

Mammary serine protease inhibitor (Maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnership.

Bailey CM, Khalkhali-Ellis Z, Kondo S, Margaryan NV, Seftor RE, Wheaton WW, Amir S, Pins MR, Schutte BC, Hendrix MJ.

J Biol Chem. 2005 Oct 7;280(40):34210-7. Epub 2005 Jul 26.

18.

Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.

Amir S, Margaryan NV, Odero-Marah V, Khalkhali-Ellis Z, Hendrix MJ.

Cancer Biol Ther. 2005 Apr;4(4):400-6. Epub 2005 Apr 21.

19.

Dual roles of E-cadherin in prostate cancer invasion.

Chunthapong J, Seftor EA, Khalkhali-Ellis Z, Seftor RE, Amir S, Lubaroff DM, Heidger PM Jr, Hendrix MJ.

J Cell Biochem. 2004 Mar 1;91(4):649-61.

PMID:
14991757
20.

Regulating the tumor suppressor gene maspin in breast cancer cells: a potential mechanism for the anticancer properties of tamoxifen.

Khalkhali-Ellis Z, Christian AL, Kirschmann DA, Edwards EM, Rezaie-Thompson M, Vasef MA, Gruman LM, Seftor RE, Norwood LE, Hendrix MJ.

Clin Cancer Res. 2004 Jan 15;10(2):449-54.

21.

Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells.

Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, Amir S, Seftor RE, Seftor EA, Hendrix MJ.

Cancer Biol Ther. 2003 Jul-Aug;2(4):398-403.

PMID:
14508113
22.
23.
24.

The paradoxical expression of maspin in ovarian carcinoma.

Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA, Hendrix MJ.

Clin Cancer Res. 2002 Sep;8(9):2924-32.

25.

Tyrosine phosphorylation of maspin in normal mammary epithelia and breast cancer cells.

Odero-Marah VA, Khalkhali-Ellis Z, Schneider GB, Seftor EA, Seftor RE, Koland JG, Hendrix MJ.

Biochem Biophys Res Commun. 2002 Jul 26;295(4):800-5.

PMID:
12127964
26.

Steroid sulfatase activity and expression in mammary myoepithelial cells.

Tobacman JK, Hinkhouse M, Khalkhali-Ellis Z.

J Steroid Biochem Mol Biol. 2002 May;81(1):65-8.

PMID:
12127043
27.

Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts.

Ray NB, Nieva DR, Seftor EA, Khalkhali-Ellis Z, Naides SJ.

Arthritis Rheum. 2001 Jul;44(7):1582-6.

28.

Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: implications in rheumatoid arthritis.

Khalkhali-Ellis Z, Seftor EA, Nieva DR, Handa RJ, Price RH Jr, Kirschmann DA, Baragi VM, Sharma RV, Bhalla RC, Moore TL, Hendrix MJ.

J Rheumatol. 2000 Jul;27(7):1622-31.

PMID:
10914842
29.

C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors.

Khalkhali-Ellis Z, Bulla GA, Schlesinger LS, Kirschmann DA, Moore TL, Hendrix MJ.

J Immunol. 1999 Oct 15;163(8):4612-20.

31.

Expression of macrophage markers by a population of T cells obtained from synovial fluid of a subgroup of patients with juvenile rheumatoid arthritis.

Khalkhali-Ellis Z, Roodman ST, Knutsen AP, Mueller KR, Chauhan B, Moore TL, Hendrix MJ.

J Rheumatol. 1998 Feb;25(2):352-60.

PMID:
9489834
32.

Induction of invasive and degradative phenotype in normal synovial fibroblasts exposed to synovial fluid from patients with juvenile rheumatoid arthritis: role of mononuclear cell population.

Khalkhali-Ellis Z, Seftor EA, Nieva DR, Seftor RE, Samaha HA, Bultman L, De Larco JE, Ince A, Moore TL, Hendrix MJ.

J Rheumatol. 1997 Dec;24(12):2451-60.

PMID:
9415657
34.

An in vitro Model for Studying Mechanisms Underlying Synoviocyte-Mediated Cartilage Invasion in Rheumatoid Arthritis.

Frye CA, Yocum DE, Tuan R, Suyana E, Seftor EA, Seftor RE, Khalkhali-Ellis Z, Moore TL, Hendrix MJ.

Pathol Oncol Res. 1996;2(3):157-166.

35.

HL-60 cell differentiation and osteopontin expression.

Berry JE, Somerman MJ, Khalkhali-Ellis Z, Osdoby P, Simpson RU.

Ann N Y Acad Sci. 1995 Apr 21;760:302-4. No abstract available.

36.

Enhanced expression of alpha v integrin subunit and osteopontin during differentiation of HL-60 cells along the monocytic pathway.

Somerman MJ, Berry JE, Khalkhali-Ellis Z, Osdoby P, Simpson RU.

Exp Cell Res. 1995 Feb;216(2):335-41.

PMID:
7843278
37.
38.

Abnormal fibronectin produced in tuberous sclerosis.

Khalkhali-Ellis Z, Hemming FW.

Ann N Y Acad Sci. 1991;615:361-2. No abstract available.

PMID:
2039158
39.

Glycoprotein and proteoglycan alterations in tuberous sclerosis.

Khalkhali-Ellis Z, Henderson K, Hemming FW.

Ann N Y Acad Sci. 1991;615:149-57. No abstract available.

PMID:
2039140
40.

Glycoconjugates of the tectorial membrane.

Khalkhali-Ellis Z, Hemming FW, Steel KP.

Hear Res. 1987;25(2-3):185-91.

PMID:
3558127

Supplemental Content

Loading ...
Support Center